Citations (148)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Yukako Ohyama, Kazuki Nakajima, Matthew B. Renfrow, Jan Novak & Kazuo Takahashi. (2020) Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins. Expert Review of Proteomics 17:4, pages 275-296.
Read now
Read now
Peifeng Tang, Jianlin Xu, Alastair Louey, Zhijun Tan, Andrew Yongky, Shaoyan Liang, Zheng Jian Li, Yongyan Weng & Shijie Liu. (2020) Kinetic modeling of Chinese hamster ovary cell culture: factors and principles. Critical Reviews in Biotechnology 40:2, pages 265-281.
Read now
Read now
Elisabeth Lobner, Anne-Sophie Humm, Georg Mlynek, Konstantin Kubinger, Michael Kitzmüller, Michael W. Traxlmayr, Kristina Djinović-Carugo & Christian Obinger. (2017) Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex. mAbs 9:7, pages 1088-1104.
Read now
Read now
Shabazz Novarra, Luba Grinberg, Keith W. Rickert, Arnita Barnes, Susan Wilson & Manuel Baca. (2016) A hingeless Fc fusion system for site-specific cleavage by IdeS. mAbs 8:6, pages 1118-1125.
Read now
Read now
Markus Haberger, Michael Leiss, Anna-Katharina Heidenreich, Oxana Pester, Georg Hafenmair, Michaela Hook, Lea Bonnington, Harald Wegele, Markus Haindl, Dietmar Reusch & Patrick Bulau. (2016) Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry . mAbs 8:2, pages 331-339.
Read now
Read now
Felix Unverdorben, Fabian Richter, Meike Hutt, Oliver Seifert, Pauline Malinge, Nicolas Fischer & Roland E. Kontermann. (2016) Pharmacokinetic properties of IgG and various Fc fusion proteins in mice. mAbs 8:1, pages 120-128.
Read now
Read now
Haixia Wu, Kristopher Truncali, Julie Ritchie, Rachel Kroe-Barrett, Sanjaya Singh, Anne S Robinson & Christopher J Roberts. (2015) Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1. mAbs 7:6, pages 1072-1083.
Read now
Read now
Markus Haberger, Anna-Katharina Heidenreich, Tilman Schlothauer, Michaela Hook, Jana Gassner, Katrin Bomans, Michelle Yegres, Adrian Zwick, Boris Zimmermann, Harald Wegele, Lea Bonnington, Dietmar Reusch & Patrick Bulau. (2015) Functional assessment of antibody oxidation by native mass spectrometry. mAbs 7:5, pages 891-900.
Read now
Read now
Tianlei Ying, Yang Feng, Yanping Wang, Weizao Chen & Dimiter S. Dimitrov. (2014) Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseases. mAbs 6:5, pages 1201-1210.
Read now
Read now
Janice M Reichert, Alain Beck, Alexey A Lugovskoy, Thierry Wurch, Steven Coats & Randall J Brezski. (2014) 9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland. mAbs 6:2, pages 309-326.
Read now
Read now
Markus Haberger, Katrin Bomans, Katharina Diepold, Michaela Hook, Jana Gassner, Tilman Schlothauer, Adrian Zwick, Christian Spick, Jochen Felix Kepert, Brigitte Hienz, Michael Wiedmann, Hermann Beck, Philipp Metzger, Michael Mølhøj, Constanze Knoblich, Ulla Grauschopf, Dietmar Reusch & Patrick Bulau. (2014) Assessment of chemical modifications of sites in the CDRs of recombinant antibodies. mAbs 6:2, pages 327-339.
Read now
Read now
Louise Saul, Louise Saul, Debra H Josephs, Debra H Josephs, Keith Cutler, Keith Cutler, Andrew Bradwell, Andrew Bradwell, Panagiotis Karagiannis, Panagiotis Karagiannis, Chris Selkirk, Chris Selkirk, Hannah J Gould, Hannah J Gould, Paul Jones, Paul Jones, James F Spicer, James F Spicer, Sophia N Karagiannis & Sophia N Karagiannis. (2014) Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potency. mAbs 6:2, pages 509-522.
Read now
Read now
Patrick M Buck, Sandeep Kumar & Satish K Singh. (2013) Consequences of glycan truncation on Fc structural integrity. mAbs 5:6, pages 904-916.
Read now
Read now
Alain Beck & Janice M. Reichert. (2013) Approval of the first biosimilar antibodies in Europe. mAbs 5:5, pages 621-623.
Read now
Read now
Heather Lynaugh, Huijuan Li & Bing Gong. (2013) Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometry. mAbs 5:5, pages 641-645.
Read now
Read now
Alain Beck, Paul J. Carter, Hans-Peter Gerber, Alexey A. Lugovskoy, Thierry Wurch, Jagath R. Junutula, Roland E Kontermann & Robert Mabry. (2013) 8th Annual European Antibody Congress 2012. mAbs 5:3, pages 339-357.
Read now
Read now
Petrus J. Pauwels, Charles Dumontet, Janice M. Reichert, Alain Beck, Liliane Goetsch, Nathalie Corvaïa, Christian Klein, Bertrand Coiffier & Beverly A. Teicher. (2012) 7th Cancer Scientific Forum of the Cancéropôle Lyon Auvergne Rhône-Alpes. mAbs 4:4, pages 434-444.
Read now
Read now
Articles from other publishers (131)
Karen Liao, Harald Mackenzie, Sihem Ait‐Oudhia, Solaiappan Manimaran, Yiyuan Zeng, Tad Akers, Tatyana Yun & Janethe de Oliveira Pena. (2023) The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension. Clinical Pharmacology & Therapeutics.
Crossref
Crossref
Miki Yokoyama, Eiko Suzuki, Masataka Oitate & Nobuaki Watanabe. (2023) A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins. European Journal of Drug Metabolism and Pharmacokinetics 48:5, pages 541-552.
Crossref
Crossref
Nancy, Sudarshan Singh Lakhawat, Sanjeev Chandel, Sunil Kumar Jaswal & Pushpender Kumar Sharma. (2023) Protein Engineering, a Robust Tool to Engineer Novel Functions in Protein. Protein & Peptide Letters 30:7, pages 541-551.
Crossref
Crossref
Soyeon Oh, Kibum Kim, Yang Joo Kang, Hyunjoo Hwang, Yerin Kim, Peter Hinterdorfer, Mi Kyung Kim, Kinarm Ko, Young Koung Lee, Do-Sun Kim, Soon Chul Myung & Kisung Ko. (2023) Co-transient expression of PSA-Fc and PAP-Fc fusion protein in plant as prostate cancer vaccine candidates and immune responses in mice. Plant Cell Reports 42:7, pages 1203-1215.
Crossref
Crossref
Jeffrey K. Actor, Thao K. T. Nguyen, Agnieszka Wasik-Smietana & Marian L. Kruzel. (2022) Modulation of TDM-induced granuloma pathology by human lactoferrin: a persistent effect in mice. BioMetals 36:3, pages 603-615.
Crossref
Crossref
Tehreem Mahmood, Areej Shahbaz, Nazim Hussain, Rahat Ali, Hamid Bashir & Komal Rizwan. (2023) Recent advancements in fusion protein technologies in oncotherapy: A review. International Journal of Biological Macromolecules 230, pages 123161.
Crossref
Crossref
Firas Hamdan & Vincenzo Cerullo. (2023) Cancer immunotherapies: A hope for the uncurable?. Frontiers in Molecular Medicine 3.
Crossref
Crossref
Abhishek Pathak, Satya Pal Singh, Apoorv Tiwari, Atul Mani Tripathi, Tarannum Jahan & Dev Bukhsh Singh. 2023. Protein-based Therapeutics. Protein-based Therapeutics
325
353
.
Chunha Shin, Kibum Kim, Yang Joo Kang, Deuk-Su Kim, Young-Jin Seo, Se Ra Park, Mi Kyung Kim, Young Koung Lee, Do-Sun Kim & Kisung Ko. (2022) Effect of IgG Fc-fusion and KDEL-ER retention signal on prostate-specific antigen expression in plant and its immune in mice. Plant Biotechnology Reports 16:6, pages 729-740.
Crossref
Crossref
Jiří Vymětal, Kateřina Mertová, Kristýna Boušová, Josef Šulc, Konstantinos Tripsianes & Jiri Vondrasek. (2022)
Fusion of two unrelated protein domains in a chimera protein and its
3D
prediction: Justification of the x‐ray reference structures as a prediction benchmark
. Proteins: Structure, Function, and Bioinformatics 90:12, pages 2067-2079.
Crossref
Crossref
Hyung Jin Jeon, Bo Kyoung Choi, Seo In Hwang, Soo Hyun Kim, Gil Jung Kim, Jae Chan Park, Zung Yoon Yang & Kwang Yeon Hwang. (2022) Optimization for Simultaneous Removal of Product/Process-Related Impurities of Peptide Fc-Fusion Protein Using Cation Exchange Chromatography. Processes 10:11, pages 2359.
Crossref
Crossref
Ettore Gilardoni & Luca Regazzoni. (2022) Liquid phase separation techniques for the characterization of monoclonal antibodies and bioconjugates. Journal of Chromatography Open 2, pages 100034.
Crossref
Crossref
Gustavo J. Cavallero, Yan Wang, Charles Nwosu, Sheng Gu, Muthuraman Meiyappan & Joseph Zaia. (2022) O-Glycoproteomic analysis of engineered heavily glycosylated fusion proteins using nanoHILIC-MS. Analytical and Bioanalytical Chemistry 414:27, pages 7855-7863.
Crossref
Crossref
A. N. Afanasyeva, V. B. Saparova, D. D. Karal-Ogly, E. I. Mukhametzyanova, D. V. Kurkin, A. V. Kalatanova, I. E. Makarenko, A. L. Khokhlov & I. A. Lugovik. (2022) SAFETY STUDY OF ROMIPLOSTIM BIOSIMILAR. Pharmacy & Pharmacology 10:4, pages 354-370.
Crossref
Crossref
Eugene M. Obeng, Isaac Fianu & Michael K. Danquah. (2022) Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine development. Nano Today 46, pages 101580.
Crossref
Crossref
Helen Haixia Wu, Maureen Crames, Yangjie Wei, Dongmei Liu, Kristina Gueneva-Boucheva, Ikbae Son, Lee Frego, Fei Han, Rachel Kroe-Barrett, Andrew Nixon & Michael Marlow. (2022) Effect of the ADCC-Modulating Mutations and the Selection of Human IgG Isotypes on Physicochemical Properties of Fc. Journal of Pharmaceutical Sciences 111:9, pages 2411-2421.
Crossref
Crossref
Abigael E. Chaouat, Ilija Brizic, Paola Kucan Brlic, Nofar Atari, Limor Kliker, Or Alfi, Michal Mandelboim, Dana Wolf, Laith Tafish, Inbal Kol, Stipan Jonjic & Ofer Mandelboim. (2022) Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern. iScience 25:9, pages 104935.
Crossref
Crossref
Yan Zheng, Ruolin Xu, Siyi Chen & Wanyi Tai. (2022) In vivo therapeutic effects of small molecule-drug conjugates enhanced by Fc grafting. Biomaterials, pages 121820.
Crossref
Crossref
Julien Camperi, Sanket Dahotre, Davy Guillarme & Cinzia Stella. (2022) Monitoring multiple quality attributes of a complex Fc-fusion protein during cell culture production processes by mD-LC-MS peptide mapping. Talanta 246, pages 123519.
Crossref
Crossref
Yan-Xin Niu, Zhao-Xu Xu, Li-Feng Yu, Yong-Ping Lu, Yan Wang, Ce Wu, Yi-Bo Hou, Jia-Ning Li, Shengqiang Huang, Xinyue Song, Xinyu Wang, Jiaqi Wang, Binyu Li, Yingrui Guo, Zhaojin Yu, Lin Zhao, Dong-Xu Yi & Min-Jie Wei. (2022) Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy. International Immunopharmacology 109, pages 108783.
Crossref
Crossref
Sayaka Nagata, Motoo Yamasaki, Nobuko Kuroishi & Kazuo Kitamura. (2022) Development of Long-Acting Human Adrenomedullin Fc-Fusion Proteins. Biology 11:7, pages 1074.
Crossref
Crossref
Tingkai Chen, Tianyu Sun, Yaoyao Bian, Yuqiong Pei, Feng Feng, Heng Chi, Yuan Li, Xu Tang, Shenghu Sang, Chenxi Du, Ying Chen, Yao Chen & Haopeng Sun. (2022) The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases. Journal of Medicinal Chemistry 65:5, pages 3685-3705.
Crossref
Crossref
Ingrid Grunert, Katrin Heinrich, Juliane Ernst, Michael Hingar, Alexandre Briguet, Michael Leiss, Manfred Wuhrer, Dietmar Reusch & Patrick Bulau. (2022) Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability. ACS Omega 7:4, pages 3671-3679.
Crossref
Crossref
Gang Wu, Chuanfei Yu, Wenbo Wang, Rongjian Zhang, Meng Li & Lan Wang. (2022) A platform method for charge heterogeneity characterization of fusion proteins by icIEF. Analytical Biochemistry 638, pages 114505.
Crossref
Crossref
Robert S. Foti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
716
742
.
Abigael Eva Chaouat, Hagit Achdout, Inbal Kol, Orit Berhani, Gil Roi, Einat B. Vitner, Sharon Melamed, Boaz Politi, Eran Zahavy, Ilija Brizic, Tihana Lenac Rovis, Or Alfi, Dana Wolf, Stipan Jonjic, Tomer Israely & Ofer Mandelboim. (2021) SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection. PLOS Pathogens 17:12, pages e1010175.
Crossref
Crossref
Markus Haberger, Anna-Katharina Heidenreich, Michaela Hook, Jürgen Fichtl, Rainer Lang, Florian Cymer, Mahdi Adibzadeh, Felix Kuhne, Harald Wegele, Dietmar Reusch, Lea Bonnington & Patrick Bulau. (2021) Multiattribute Monitoring of Antibody Charge Variants by Cation-Exchange Chromatography Coupled to Native Mass Spectrometry. Journal of the American Society for Mass Spectrometry 32:8, pages 2062-2071.
Crossref
Crossref
Dhanashri Bagal & Bradford W. Gibson. (2021) Identification of Proteolysis Products in Protein Therapeutics through TMPP N-Terminal Tagging and Electron Transfer Dissociation Product Triggered Collisional Induced Dissociation Fragmentation. Journal of the American Society for Mass Spectrometry 32:8, pages 1936-1944.
Crossref
Crossref
H.A. Daniel Lagassé, Louis B. Hopkins, Wojciech Jankowski, Marc G. Jacquemin, Zuben E. Sauna & Basil Golding. (2021) Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16. Frontiers in Immunology 12.
Crossref
Crossref
Svenja Feldmann, Immanuel Grimm, Dagmar Stöhr, Chiara Antonini, Peter Lischka, Christian Sinzger & Cora Stegmann. (2021) Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration. PLOS Pathogens 17:3, pages e1009471.
Crossref
Crossref
Xiurong Zhao, Marian Kruzel, Shun-Ming Ting, Guanghua Sun, Sean I Savitz & Jaroslaw Aronowski. (2020) Optimized lactoferrin as a highly promising treatment for intracerebral hemorrhage: Pre-clinical experience. Journal of Cerebral Blood Flow & Metabolism 41:1, pages 53-66.
Crossref
Crossref
Bastiaan L. Duivelshof, Amarande Murisier, Julien Camperi, Szabolcs Fekete, Alain Beck, Davy Guillarme & Valentina D'Atri. (2020) Therapeutic Fc‐fusion proteins: Current analytical strategies. Journal of Separation Science 44:1, pages 35-62.
Crossref
Crossref
Banghui Zhu, Guosheng Wu, Chen Wang, Yongqiang Xiao, Jian Jin, Kangan Wang, Yong Jiang, Yu Sun, Daofeng Ben & Zhaofan Xia. (2020) Soluble cluster of differentiation 74 regulates lung inflammation through the nuclear factor-κB signaling pathway. Immunobiology 225:5, pages 152007.
Crossref
Crossref
Yinhsuan Michely Chen, Shu Qi, Stephanie Perrino, Masakazu Hashimoto & Pnina Brodt. (2020) Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug. Cells 9:5, pages 1098.
Crossref
Crossref
Yajing Wang. (2020) Recombinant Elabela-Fc fusion protein has extended plasma half-life and mitigates post-infarct heart dysfunction in rats. International Journal of Cardiology 300, pages 217-218.
Crossref
Crossref
Adrian P. Defante, Cavan K. Kalonia, Emma Keegan, Steven M. Bishop, Hasige A. Satish, Steven D. Hudson & Paul V. Santacroce. (2020) The Impact of the Metal Interface on the Stability and Quality of a Therapeutic Fusion Protein. Molecular Pharmaceutics.
Crossref
Crossref
Steven A. Berkowitz & Damian J. Houde. 2020. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
3
26
.
Jyoti Singh Jadaun, Lokesh Kumar Narnoliya, Archana Srivastava & Sudhir P. Singh. 2020. Biomass, Biofuels, Biochemicals. Biomass, Biofuels, Biochemicals
119
143
.
Simone Schadt, Simon Hauri, Filipe Lopes, Martin R. Edelmann, Roland F. Staack, Roberto Villaseñor, Hubert Kettenberger, Adrian B. Roth, Franz Schuler, Wolfgang F. Richter & Christoph Funk. (2019) Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges. Drug Metabolism and Disposition 47:12, pages 1443-1456.
Crossref
Crossref
Guilhem Bousquet, Jean-Paul Feugeas, Yuchen Gu, Christophe Leboeuf, Morad El Bouchtaoui, He Lu, Marc Espié, Anne Janin & Melanie Di Benedetto. (2019) High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target. Oncotarget 10:61, pages 6577-6588.
Crossref
Crossref
K. Varini, P. Lécorché, R. Sonnette, F. Gassiot, B. Broc, M. Godard, M. David, A. Faucon, K. Abouzid, G. Ferracci, J. Temsamani, M. Khrestchatisky & G. Jacquot. (2019) Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: Implications for the rational design of new targeted drug therapies. Journal of Controlled Release 314, pages 141-161.
Crossref
Crossref
Arjun Jain, Charles Coffey, Vidhi Mehrotra & Josef Flammer. (2019) Endothelin-1 traps as a potential therapeutic tool: from diabetes to beyond?. Drug Discovery Today 24:9, pages 1937-1942.
Crossref
Crossref
Keith J. Arlotta & Shawn C. Owen. (2019) Antibody and antibody derivatives as cancer therapeutics. WIREs Nanomedicine and Nanobiotechnology 11:5.
Crossref
Crossref
Yun Jung Kim, Senem Ertan‐Ahmed, Yilmaz Capan & Sang In Yang. (2019) Preclinical evaluation of a biobetter candidate: Pharmacokinetics and pharmacodynamics of GX‐G3 in healthy and neutropenia‐induced rats. Drug Development Research 80:6, pages 807-813.
Crossref
Crossref
Sayaka Nagata, Motoo Yamasaki, Aya Kawano & Kazuo Kitamura. (2019) Developments of human adrenomedullin-IgG1 Fc fusion proteins. The Journal of Biochemistry 166:2, pages 157-162.
Crossref
Crossref
H. A. Daniel Lagassé, Hartmut Hengel, Basil Golding & Zuben E. Sauna. (2019) Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity. The AAPS Journal 21:4.
Crossref
Crossref
Shengze Yu, Amira Alkharusi, Gunnar Norstedt & Torbjörn Gräslund. (2019) An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation. PLOS ONE 14:5, pages e0215831.
Crossref
Crossref
Wenrong Yao, Lei Yu, Wenhong Fan, Xinchang Shi, Lan Liu, Yonghong Li, Xi Qin, Chunming Rao & Junzhi Wang. (2019) A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone. Molecules 24:7, pages 1389.
Crossref
Crossref
Arjun Jain, Vidhi Mehrotra, Hannah Yong, Kirti Hiremath, Ashok Jain, Martin Johnson & Ira Jha. (2017) Creating a Soluble Binder to Endothelin-1 Based on the Natural Ligand Binding Domains of the Endothelin-1 (G-Protein-Coupled) Receptor. International Journal of Peptide Research and Therapeutics 25:1, pages 107-114.
Crossref
Crossref
Ye Hou, Hang Su, Zhiying Luo, Mingying Li, Xiaonan Ma & Ningning Ma. (2019) Nutrient Optimization Reduces Phosphorylation and Hydroxylation Level on an Fc-Fusion Protein in a CHO Fed-Batch Process. Biotechnology Journal 14:3, pages 1700706.
Crossref
Crossref
Atefeh Ghorbani Aghdam, Saeed Moradhaseli, Farnoush Jafari, Paria Motahari, Sepideh Samavat, Rasoul Mahboudi & Shayan Maleknia. (2019) Therapeutic Fc fusion protein misfolding: A three-phasic cultivation experimental design. PLOS ONE 14:1, pages e0210712.
Crossref
Crossref
Xing Jing, Yan Hou, William Hallett, Chandrahas G. Sahajwalla & Ping Ji. 2019. Therapeutic Enzymes: Function and Clinical Implications. Therapeutic Enzymes: Function and Clinical Implications
115
129
.
Mikhail Yu. Samsonov, A. A Dmitrieva, G. E Konopleva, E. V Shipaeva, S. F Barbashov & Ya. V Lavrovsky. (2018) NONCLINICAL STUDIES OF BIOTECHNOLOGY DERIVED MEDICINAL PRODUCTS - THEORY AND PRACTICE SPECIFICITY. Medical Journal of the Russian Federation 24:6, pages 324-331.
Crossref
Crossref
Md. Kausar Alam, Michelle Brabant, Raja Solomon Viswas, Kris Barreto, Humphrey Fonge & C. Ronald Geyer. (2018) A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system. BMC Biotechnology 18:1.
Crossref
Crossref
Ruijing Huang, Jian Li, Yibo Wang, Lihua Zhang, Xiaohui Ma, Hongyu Wang, Wenlei Li, Xiaodan Cao, Hanmei Xu & Jialiang Hu. (2018) The Protective Effect of a Long-Acting and Multi-Target HM-3-Fc Fusion Protein in Rheumatoid Arthritis. International Journal of Molecular Sciences 19:9, pages 2683.
Crossref
Crossref
Tae Yoon Kim, Hyo-Deok Seo, Joong-jae Lee, Jung Ae Kang, Woo Sik Kim, Hye-Min Kim, Ha-Yeon Song, Ji Min Park, Dong-Eun Lee & Hak-Sung Kim. (2018) A dimeric form of a small-sized protein binder exhibits enhanced anti-tumor activity through prolonged blood circulation. Journal of Controlled Release 279, pages 282-291.
Crossref
Crossref
Ingrid Schmid, Lea Bonnington, Monika Gerl, Katrin Bomans, Anna Louisa Thaller, Katharina Wagner, Tilman Schlothauer, Roberto Falkenstein, Boris Zimmermann, Jürgen Kopitz, Max Hasmann, Frieder Bauss, Markus Haberger, Dietmar Reusch & Patrick Bulau. (2018) Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions. Communications Biology 1:1.
Crossref
Crossref
Ambrose J. Williams, Glen S. Giese, Andreas Schaubmar & Thomas von Hirschheydt. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing
837
855
.
Roman Mathaes & Hanns-Christian Mahler. 2018. New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins. New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins
253
276
.
Liang Xu, Andrea Carrer, Francesco Zonta, Zhihu Qu, Peixiang Ma, Sheng Li, Federico Ceriani, Damiano Buratto, Giulia Crispino, Veronica Zorzi, Gaia Ziraldo, Francesca Bruno, Chiara Nardin, Chiara Peres, Flavia Mazzarda, Anna M. Salvatore, Marcello Raspa, Ferdinando Scavizzi, Youjun Chu, Sichun Xie, Xuemei Yang, Jun Liao, Xiao Liu, Wei Wang, Shanshan Wang, Guang Yang, Richard A. Lerner & Fabio Mammano. (2017) Design and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin Disorders. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Alicja Sochaj-Gregorczyk, Patryk Ludzia, Emilia Kozdrowska, Piotr Jakimowicz, Aleksandra Sokolowska-Wedzina & Jacek Otlewski. (2017) Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1. International Journal of Molecular Sciences 18:8, pages 1688.
Crossref
Crossref
Derek R. White, Zahra Khedri, Paul Kiptoo, Teruna J. Siahaan & Thomas J. Tolbert. (2017) Synthesis of a Bifunctional Peptide Inhibitor–IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis. Bioconjugate Chemistry 28:7, pages 1867-1877.
Crossref
Crossref
Michael T. Furlong. 2017. Protein Analysis using Mass Spectrometry. Protein Analysis using Mass Spectrometry
161
181
.
D. Levin, H.A.D. Lagassé, E. Burch, S. Strome, S. Tan, H. Jiang, Z.E. Sauna & B. Golding. (2017) Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model. Journal of Thrombosis and Haemostasis 15:4, pages 721-734.
Crossref
Crossref
Youngbin Baek, Nripen Singh, Abhiram Arunkumar & Andrew Zydney. (2017) Ultrafiltration behavior of an Fc-fusion protein: Filtrate flux data and modeling. Journal of Membrane Science 528, pages 171-177.
Crossref
Crossref
Abhinav A. Shukla & Carnley L. Norman. 2017. Process Scale Purification of Antibodies. Process Scale Purification of Antibodies
559
594
.
Abhinav A. Shukla, Leslie S. Wolfe, Sigma S. Mostafa & Carnley Norman. (2017) Evolving trends in mAb production processes. Bioengineering & Translational Medicine 2:1, pages 58-69.
Crossref
Crossref
Majlinda Kullolli, Dan A. Rock & Ji Ma. (2016) Immuno-affinity Capture Followed by TMPP N-Terminus Tagging to Study Catabolism of Therapeutic Proteins. Journal of Proteome Research 16:2, pages 911-919.
Crossref
Crossref
Kalimuthu Karuppanan, Sifti Duhra-Gill, Muchena Kailemia, My Phu, Carlito Lebrilla, Abhaya Dandekar, Raymond Rodriguez, Somen Nandi & Karen McDonald. (2017) Expression, Purification, and Biophysical Characterization of a Secreted Anthrax Decoy Fusion Protein in Nicotiana benthamiana. International Journal of Molecular Sciences 18:1, pages 89.
Crossref
Crossref
Huili Guo, Yadong Yang, Feiyan Xue, Hong Zhang, Tiran Huang, Wenbin Liu, Huan Liu, Fenqiang Zhang, Mingfeng Yang, Chunmei Liu, Heshu Lu, Yansheng Zhang & Lanqing Ma. (2017) Effect of flexible linker length on the activity of fusion protein 4-coumaroyl-CoA ligase::stilbene synthase. Mol. BioSyst. 13:3, pages 598-606.
Crossref
Crossref
A.A. Shukla, L. Wolfe & C. Norman. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
171
179
.
Tao Liu, Huaizu Guo, Lei Zhu, Yingxin Zheng, Jin Xu, Qingcheng Guo, Dapeng Zhang, Weizhu Qian, Jianxin Dai, Yajun Guo, Sheng Hou & Hao Wang. (2016) Fast Characterization of Fc-Containing Proteins by Middle-Down Mass Spectrometry Following IdeS Digestion. Chromatographia 79:21-22, pages 1491-1505.
Crossref
Crossref
Orit Jacobson, Dale O. Kiesewetter & Xiaoyuan Chen. (2016) Albumin-Binding Evans Blue Derivatives for Diagnostic Imaging and Production of Long-Acting Therapeutics. Bioconjugate Chemistry 27:10, pages 2239-2247.
Crossref
Crossref
Rosie Upton, Kamila J. Pacholarz, David Firth, Sian Estdale & Perdita E. Barran. 2016. Analysis of Protein Post‐Translational Modifications by Mass Spectrometry. Analysis of Protein Post‐Translational Modifications by Mass Spectrometry
351
385
.
Dwight Stoll, John Danforth, Kelly Zhang & Alain Beck. (2016) Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection. Journal of Chromatography B 1032, pages 51-60.
Crossref
Crossref
Rabah Gahoual, Alain Beck, Emmanuelle Leize-Wagner & Yannis-Nicolas François. (2016) Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products. Journal of Chromatography B 1032, pages 61-78.
Crossref
Crossref
Lu Shan, Magali Colazet, Kim L. Rosenthal, Xiang-Qing Yu, Jared S. Bee, Andrew Ferguson, Melissa M. Damschroder, Herren Wu, William F. Dall’Acqua, Ping Tsui & Vaheh Oganesyan. (2016) Generation and Characterization of an IgG4 Monomeric Fc Platform. PLOS ONE 11:8, pages e0160345.
Crossref
Crossref
Sanjukta Chakrabarti, Colin Barrow, Rupinder Kanwar, Venkata Ramana & Jagat Kanwar. (2016) Studies to Prevent Degradation of Recombinant Fc-Fusion Protein Expressed in Mammalian Cell Line and Protein Characterization. International Journal of Molecular Sciences 17:6, pages 913.
Crossref
Crossref
Masumi Iijima, Nobuo Yoshimoto, Tomoaki Niimi, Andr?s D. Maturana & Shun'ichi Kuroda. (2016) Bio-nanocapsule-based scaffold improves the sensitivity and ligand-binding capacity of mammalian receptors on the sensor chip. Biotechnology Journal 11:6, pages 805-813.
Crossref
Crossref
João Pedro Martins, Patrick J. Kennedy, Hélder A. Santos, Cristina Barrias & Bruno Sarmento. (2016) A comprehensive review of the neonatal Fc receptor and its application in drug delivery. Pharmacology & Therapeutics 161, pages 22-39.
Crossref
Crossref
E. Villama??n, D. Gonz?lez, E. Armada, M. Ruano, R. ?lvarez-Sala & A. Herrero. (2016) Juego de patentes. Sobre medicamentos gen?ricos y biosimilares. Revista de Calidad Asistencial 31:2, pages 99-105.
Crossref
Crossref
Xiaojie YuMelissa MenardJózsef Prechl, Varsha Bhakta, William P. Sheffield & Alan H. Lazarus. (2016) Monovalent Fc receptor blockade by an anti–Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity. Blood 127:1, pages 132-138.
Crossref
Crossref
Szabolcs Fekete, Davy Guillarme, Pat Sandra & Koen Sandra. (2015) Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein Biopharmaceuticals. Analytical Chemistry 88:1, pages 480-507.
Crossref
Crossref
Theresa Yuraszeck & Megan Gibbs. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
15
.
Andrew G. Popplewell. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
11
.
Josh T Pearson & Dan A Rock. (2015) Bioanalytical approaches to assess the proteolytic stability of therapeutic fusion proteins. Bioanalysis 7:23, pages 3035-3051.
Crossref
Crossref
Tao Liu, Juanjuan Du, Xiaozhou Luo, Peter G Schultz & Feng Wang. (2015) Homogeneously modified immunoglobulin domains for therapeutic application. Current Opinion in Chemical Biology 28, pages 66-74.
Crossref
Crossref
Szabolcs Fekete, Alain Beck, Jean-Luc Veuthey & Davy Guillarme. (2015) Ion-exchange chromatography for the characterization of biopharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis 113, pages 43-55.
Crossref
Crossref
Jiying Fan, Liying Huang, Jing Sun, Yi Qiu, Jinsong Zhou & Yaling Shen. (2015) Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity. Journal of Biotechnology 209, pages 16-22.
Crossref
Crossref
William R. Strohl. (2015) Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters. BioDrugs 29:4, pages 215-239.
Crossref
Crossref
Liming Liu. (2015) Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins. Journal of Pharmaceutical Sciences 104:6, pages 1866-1884.
Crossref
Crossref
Jianfei Huang, Qi Tang, Changjun Wang, Huixin Yu, Zhenqing Feng & Jin Zhu. (2015) Molecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric Fab. Scientific Reports 5:1.
Crossref
Crossref
Brian A. Baldo. (2015) Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety. Drug Safety 38:5, pages 455-479.
Crossref
Crossref
Alain Beck, François Debaene, Hélène Diemer, Elsa Wagner-Rousset, Olivier Colas, Alain Van Dorsselaer & Sarah Cianférani. (2015) Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. Journal of Mass Spectrometry 50:2, pages 285-297.
Crossref
Crossref
Ditza Levin, Basil Golding, Scott E. Strome & Zuben E. Sauna. (2015) Fc fusion as a platform technology: potential for modulating immunogenicity. Trends in Biotechnology 33:1, pages 27-34.
Crossref
Crossref
Kai Yu, Chengcheng Liu, Byung-Gee Kim & Dong-Yup Lee. (2015) Synthetic fusion protein design and applications. Biotechnology Advances 33:1, pages 155-164.
Crossref
Crossref
Steven A. Berkowitz & Damian J. Houde. 2015. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
1
21
.
Johan SeijsingMalin LindborgIngmarie Höidén-GuthenbergHeiko BönischElin GuneriussonFredrik Y. Frejd, Lars AbrahmsénCaroline EkbladJohn LöfblomMathias Uhlén & Torbjörn Gräslund. (2014) An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein. Proceedings of the National Academy of Sciences 111:48, pages 17110-17115.
Crossref
Crossref
Szabolcs Fekete, Alain Beck, Jean-Luc Veuthey & Davy Guillarme. (2014) Theory and practice of size exclusion chromatography for the analysis of protein aggregates. Journal of Pharmaceutical and Biomedical Analysis 101, pages 161-173.
Crossref
Crossref
César Hernández-García. (2014) Biosimilar Drugs, Myths and Reality. Reumatología Clínica (English Edition) 10:6, pages 351-352.
Crossref
Crossref
César Hernández-García. (2014) Mitos y realidades sobre los medicamentos biosimilares. Reumatología Clínica 10:6, pages 351-352.
Crossref
Crossref
Claire Ginn, Hanieh Khalili, Rebecca Lever & Steve Brocchini. (2014) PEGylation and its impact on the design of new protein-based medicines. Future Medicinal Chemistry 6:16, pages 1829-1846.
Crossref
Crossref
Joo H Kang, Michael Super, Chong Wing Yung, Ryan M Cooper, Karel Domansky, Amanda R Graveline, Tadanori Mammoto, Julia B Berthet, Heather Tobin, Mark J Cartwright, Alexander L Watters, Martin Rottman, Anna Waterhouse, Akiko Mammoto, Nazita Gamini, Melissa J Rodas, Anxhela Kole, Amanda Jiang, Thomas M Valentin, Alexander Diaz, Kazue Takahashi & Donald E Ingber. (2014) An extracorporeal blood-cleansing device for sepsis therapy. Nature Medicine 20:10, pages 1211-1216.
Crossref
Crossref
Deborah J Gow, Kristin A Sauter, Clare Pridans, Lindsey Moffat, Anuj Sehgal, Ben M Stutchfield, Sobia Raza, Philippa M Beard, Yi Ting Tsai, Graeme Bainbridge, Pamela L Boner, Greg Fici, David Garcia-Tapia, Roger A Martin, Theodore Oliphant, John A Shelly, Raksha Tiwari, Thomas L Wilson, Lee B Smith, Neil A Mabbott & David A Hume. (2014) Characterisation of a Novel Fc Conjugate of Macrophage Colony-stimulating Factor. Molecular Therapy 22:9, pages 1580-1592.
Crossref
Crossref
Masato Amano, Naoki Kobayashi, Masayuki Yabuta, Susumu Uchiyama & Kiichi Fukui. (2014) Detection of Histidine Oxidation in a Monoclonal Immunoglobulin Gamma (IgG) 1 Antibody. Analytical Chemistry 86:15, pages 7536-7543.
Crossref
Crossref
Michela Silacci, Nadja Baenziger-Tobler, Wibke Lembke, Wenjuan Zha, Sarah Batey, Julian Bertschinger & Dragan Grabulovski. (2014) Linker Length Matters, Fynomer-Fc Fusion with an Optimized Linker Displaying Picomolar IL-17A Inhibition Potency. Journal of Biological Chemistry 289:20, pages 14392-14398.
Crossref
Crossref
Sara Rosati, Yang Yang, Arjan Barendregt & Albert J R Heck. (2014) Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry. Nature Protocols 9:4, pages 967-976.
Crossref
Crossref
Jody D. Berry. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins
217
232
.
Abhinav A. Shukla & Uwe Gottschalk. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins
97
114
.
Yao‐Ming Huang, Rashmi Kshirsagar, Barbara Woppmann & Thomas Ryll. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins
67
96
.
Maryam Hamzeh-Mivehroud, Ali Akbar Alizadeh, Michael B. Morris, W. Bret Church & Siavoush Dastmalchi. (2013) Phage display as a technology delivering on the promise of peptide drug discovery. Drug Discovery Today 18:23-24, pages 1144-1157.
Crossref
Crossref
Mark R. Bell, Mark J. Engleka, Asim Malik & James E. Strickler. (2013) To fuse or not to fuse: What is your purpose?. Protein Science 22:11, pages 1466-1477.
Crossref
Crossref
François Debaene, Elsa Wagner-Rousset, Olivier Colas, Daniel Ayoub, Nathalie Corvaïa, Alain Van Dorsselaer, Alain Beck & Sarah Cianférani. (2013) Time Resolved Native Ion-Mobility Mass Spectrometry to Monitor Dynamics of IgG4 Fab Arm Exchange and “Bispecific” Monoclonal Antibody Formation. Analytical Chemistry 85:20, pages 9785-9792.
Crossref
Crossref
Kakon Nag & Toshihiro Akaike. (2013) E-Cadherin – Fc Chimeric Protein-Based Biomaterial: Breaking the Barriers in Stem Cell Technology and Regenerative Medicine. Advanced Materials Research 810, pages 41-76.
Crossref
Crossref
HSUEH-TSEN CHENG & WEN-CHUN HUNG. (2013) Inhibition of proliferation, sprouting, tube formation and Tie2 signaling of lymphatic endothelial cells by the histone deacetylase inhibitor SAHA. Oncology Reports 30:2, pages 961-967.
Crossref
Crossref
J. Huang, T. Ishino, G. Chen, P. Rolzin, T. F. Osothprarop, K. Retting, L. Li, P. Jin, M. J. Matin, B. Huyghe, S. Talukdar, C. W. Bradshaw, M. Palanki, B. N. Violand, G. Woodnutt, R. W. Lappe, K. Ogilvie & N. Levin. (2013) Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody. Journal of Pharmacology and Experimental Therapeutics 346:2, pages 270-280.
Crossref
Crossref
Alain Beck, Hélène Diemer, Daniel Ayoub, François Debaene, Elsa Wagner-Rousset, Christine Carapito, Alain Van Dorsselaer & Sarah Sanglier-Cianférani. (2013) Analytical characterization of biosimilar antibodies and Fc-fusion proteins. TrAC Trends in Analytical Chemistry 48, pages 81-95.
Crossref
Crossref
Stefan R. Schmidt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
1
24
.
Liming Liu, Sujatha Gomathinayagam, Lora Hamuro, Thomayant Prueksaritanont, Weirong Wang, Terrance A. Stadheim & Stephen R. Hamilton. (2012) The Impact of Glycosylation on the Pharmacokinetics of a TNFR2:Fc Fusion Protein Expressed in Glycoengineered Pichia Pastoris. Pharmaceutical Research 30:3, pages 803-812.
Crossref
Crossref
Alain Beck, Elsa Wagner-Rousset, Daniel Ayoub, Alain Van Dorsselaer & Sarah Sanglier-Cianférani. (2012) Characterization of Therapeutic Antibodies and Related Products. Analytical Chemistry 85:2, pages 715-736.
Crossref
Crossref
Christian Kellner & Matthias Peipp. 2013. Molecular and Cellular Mechanisms of Antibody Activity. Molecular and Cellular Mechanisms of Antibody Activity
251
284
.
Liming Liu, Huijuan Li, Stephen R. Hamilton, Sujatha Gomathinayagam, William J. Rayfield, Marc van Maanen, Kuo?Chang Yin, Laura Hong & Thomayant Prueksaritanont. (2012) The Impact of Sialic Acids on the Pharmacokinetics of a PEGylated Erythropoietin. Journal of Pharmaceutical Sciences 101:12, pages 4414-4418.
Crossref
Crossref
Daniel M. Czajkowsky, Jun Hu, Zhifeng Shao & Richard J. Pleass. (2012) Fc‐fusion proteins: new developments and future perspectives. EMBO Molecular Medicine 4:10, pages 1015-1028.
Crossref
Crossref
Alain Beck, Sarah Sanglier-Cianférani & Alain Van Dorsselaer. (2012) Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry. Analytical Chemistry 84:11, pages 4637-4646.
Crossref
Crossref
Tianlei Ying, Weizao Chen, Rui Gong, Yang Feng & Dimiter S. Dimitrov. (2012) Soluble Monomeric IgG1 Fc. Journal of Biological Chemistry 287:23, pages 19399-19408.
Crossref
Crossref
Mark J. Adler & Dimiter S. Dimitrov. (2012) Therapeutic Antibodies Against Cancer. Hematology/Oncology Clinics of North America 26:3, pages 447-481.
Crossref
Crossref
Damian Houde & Steven A. Berkowitz. (2012) Conformational Comparability of Factor IX–Fc Fusion Protein, Factor IX, and Purified Fc Fragment in the Absence and Presence of Calcium. Journal of Pharmaceutical Sciences 101:5, pages 1688-1700.
Crossref
Crossref
Ramachandran Murali & Mark I. Greene. (2012) Structure Based Antibody-Like Peptidomimetics. Pharmaceuticals 5:2, pages 209-235.
Crossref
Crossref
. 2012. Therapeutic Antibody Engineering. Therapeutic Antibody Engineering
329
595
.
. 2012. Therapeutic Antibody Engineering. Therapeutic Antibody Engineering
459
595
.
Dimiter S. Dimitrov. 2012. Therapeutic Proteins. Therapeutic Proteins
1
26
.